Form D · Hedge Fund

BIOTECHNOLOGY VALUE FUND II LP

San Francisco, CA · CIK 0001102444

Offering snapshot reported Dec 23, 2025 · SEC filing

Reported sold: $1.41B
Investors reported: 123
Minimum accepted: $25M
First sale: Sep 1, 2008

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$179,922,818 → $1,406,935,818
Reported investors34 → 123
Minimum accepted$0 → $25,000,000

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Dec 23, 2025	Amendment	$1,406,935,818	$1,227,013,000vs Sep 21, 2016	123	SEC filing
Dec 27, 2024	Amendment	$1,325,635,818	$1,145,713,000vs Sep 21, 2016	118	SEC filing
Dec 29, 2023	Amendment	$1,278,335,818	$1,098,413,000vs Sep 21, 2016	115	SEC filing
Dec 30, 2022	Amendment	$1,260,272,818	$1,080,350,000vs Sep 21, 2016	114	SEC filing
Jan 4, 2022	Amendment	$1,035,372,818	$855,450,000vs Sep 21, 2016	101	SEC filing
Jan 7, 2021	Amendment	$584,922,818	$405,000,000vs Sep 21, 2016	68	SEC filing
Jan 10, 2020	Amendment	$487,122,818	$307,200,000vs Sep 21, 2016	60	SEC filing
Jan 11, 2019	Amendment	$210,422,818	$30,500,000vs Sep 21, 2016	38	SEC filing
Dec 8, 2017	Amendment	$193,222,818	$13,300,000vs Sep 21, 2016	36	SEC filing
Sep 21, 2016	Amendment	$179,922,818	$133,822,818vs Nov 12, 2014	34	SEC filing
Nov 12, 2014	Amendment	$46,100,000	$24,850,000vs Nov 8, 2013	14	SEC filing
Nov 8, 2013	Amendment	$21,250,000	$7,500,000vs Nov 8, 2012	5	SEC filing
Nov 8, 2012	Amendment	$13,750,000	$0vs Nov 8, 2011	3	SEC filing
Nov 8, 2011	Amendment	$13,750,000	$0vs Oct 21, 2010	3	SEC filing
Oct 21, 2010	Amendment	$13,750,000	$0vs Oct 16, 2009	3	SEC filing
Oct 16, 2009	Amendment	$13,750,000	No comparison	4	SEC filing
Oct 2, 2008	Paper	Not reported	No comparison	Not reported	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06b, 3C, 3C.7
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-123219

Source: Form D, filed Dec 23, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

BIOTECHNOLOGY VALUE FUND II, L.P.

Investment adviser: BVF PARTNERS L.P.

Gross asset value: $2.5B
Beneficial owners: 116
ADV minimum commitment: $25M

Reported in Form ADV on Mar 31, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator CITCO FUND ADMINISTRATION (CAYMAN ISLANDS) LIMITED CAMANA BAY, GRAND CAYMAN, Cayman Islands Investor statements: Yes (provided to all investors) Related to adviser: No

Auditor PRICEWATERHOUSECOOPERS, LLP CHICAGO, Illinois, United States

Custodian JEFFERIES LLC NEW YORK, New York, United States Related to adviser: No

Custodian THE BANK OF NEW YORK MELLON NEW YORK, New York, United States Related to adviser: No

Prime broker JEFFERIES LLC NEW YORK, New York, United States

Provider details

Annual audit: Yes
Prime brokers: Yes
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: No

PRICEWATERHOUSECOOPERS, LLP
PCAOB 238

JEFFERIES LLC
SEC 8-15074

THE BANK OF NEW YORK MELLON
LEI HPFHU0OQ28E4N0NFVK49

JEFFERIES LLC
CRD 2347 · SEC 8-15074

Filing source

Form ADV 2082729 · Mar 31, 2026 · Schedule D 7.B.(1), fund 805-6974108223

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

Related funds

Funds whose names form a numbered series with this one and that share its city or the name of a related person. Form D does not state how these funds are related.

Fund	Latest Form D	Reported sold	Investors
BIOTECHNOLOGY VALUE FUND L P	Dec 23, 2025	$1,553,132,682	29
BIOTECHNOLOGY VALUE FUND II LP (this fund)	Dec 23, 2025	$1,406,935,818	123

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
N/A Bvf Gp Holdings Llc	Executive
N/A Bvf Ii Gp Llc	Executive
N/A Bvf Inc.	Executive
N/A Bvf Partners, L.P.	Executive
Mitchell Kaye	Executive
James Kratky	Executive
Mark N. Lampert	Executive
Spike Loy	Executive
Jason Mc Cune	Executive
Oleg Nodelman	Executive
Matthew D. Perry	Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

44 Montgomery Street 40 Th Fl
San Francisco, CA, 94104